We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.74%
2 Healthcare 2.42%
3 Financials 2.31%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXTR icon
9251
CALL
Extreme Networks
EXTR
$3.2B
$504K ﹤0.01%
41,300
-10,500
-20% -$131K
GEF icon
9252
Greif
GEF
$4.97B
$504K ﹤0.01%
7,746
+2,387
+45% +$143K
REMX icon
9253
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.3B
$504K ﹤0.01%
+4,262
New +$459K
VERV
9254
PUT
DELISTED
Verve Therapeutics
VERV
$504K ﹤0.01%
22,100
+12,700
+135% +$363K
VIRX
9255
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$504K ﹤0.01%
+105,940
New +$319K
CCV
9256
PUT
DELISTED
Churchill Capital Corp V
CCV
$504K ﹤0.01%
51,300
+14,900
+41% +$146K
AMPH icon
9257
CALL
Amphastar Pharmaceuticals
AMPH
$889M
$503K ﹤0.01%
+14,000
New +$397K
HNI icon
9258
HNI Corp
HNI
$3.53B
$503K ﹤0.01%
13,581
-16,394
-55% -$662K
IWB icon
9259
iShares Russell 1000 ETF
IWB
$50.4B
$503K ﹤0.01%
2,012
-55,353
-96% -$13.7M
KOCT icon
9260
Innovator US Small Cap Power Buffer ETF October
KOCT
$131M
$503K ﹤0.01%
19,058
+10,928
+134% +$287K
NX icon
9261
Quanex
NX
$962M
$503K ﹤0.01%
23,958
-8,556
-26% -$195K
ETWO.WS
9262
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$503K ﹤0.01%
219,440
FLNC icon
9263
CALL
Fluence Energy
FLNC
$2.43B
$502K ﹤0.01%
+38,300
New +$642K
GEVO icon
9264
Gevo
GEVO
$418M
$502K ﹤0.01%
107,450
-754,054
-88% -$2.88M
HFFG icon
9265
HF Foods Group
HFFG
$99.2M
$502K ﹤0.01%
75,369
+63,535
+537% +$440K
LGOV icon
9266
First Trust Long Duration Opportunities ETF
LGOV
$622M
$502K ﹤0.01%
19,436
-3,018
-13% -$80.5K
LGF.A
9267
CALL
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$502K ﹤0.01%
30,900
-50,600
-62% -$792K
FARO
9268
DELISTED
Faro Technologies
FARO
$501K ﹤0.01%
9,635
-6,803
-41% -$380K
LEAD
9269
DELISTED
Siren DIVCON Leaders Dividend ETF
LEAD
$501K ﹤0.01%
+9,101
New +$504K
MDU icon
9270
PUT
MDU Resources
MDU
$4.34B
$501K ﹤0.01%
49,442
+17,357
+54% +$184K
RLX icon
9271
CALL
RLX Technology
RLX
$2.37B
$501K ﹤0.01%
280,000
-376,000
-57% -$1.12M
TX icon
9272
Ternium
TX
$10.6B
$501K ﹤0.01%
+10,985
New +$468K
XVV icon
9273
iShares ESG Screened S&P 500 ETF
XVV
$680M
$501K ﹤0.01%
+14,580
New +$496K
PRVB
9274
CALL
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$501K ﹤0.01%
68,400
-30,700
-31% -$184K
DLN icon
9275
WisdomTree US LargeCap Dividend Fund
DLN
$6.45B
$500K ﹤0.01%
+7,614
New +$493K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.